KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Net Margin (2016 - 2025)

Teladoc Health (TDOC) has disclosed Net Margin for 12 consecutive years, with 3.91% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 364.0% to 3.91% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.92% through Dec 2025, up 3105.0% year-over-year, with the annual reading at 7.92% for FY2025, 3105.0% up from the prior year.
  • Net Margin hit 3.91% in Q4 2025 for Teladoc Health, up from 7.91% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1.98% in Q4 2021 to a low of 1180.6% in Q1 2022.
  • Historically, Net Margin has averaged 131.2% across 5 years, with a median of 11.51% in 2022.
  • Biggest five-year swings in Net Margin: crashed -113660bps in 2022 and later surged 116960bps in 2023.
  • Year by year, Net Margin stood at 1.98% in 2021, then crashed by -30044bps to 597.47% in 2022, then surged by 99bps to 4.38% in 2023, then crashed by -73bps to 7.56% in 2024, then soared by 48bps to 3.91% in 2025.
  • Business Quant data shows Net Margin for TDOC at 3.91% in Q4 2025, 7.91% in Q3 2025, and 5.16% in Q2 2025.